European Journal of Cancer · 2021 · 44 citations · 38 references
Veterinary MedicineInfectious DiseasesOncologyImmunizationVaccinologyAntiviral StewardshipVaccinationVaccine EfficacyCovid-19 Vaccination PolicyInfection Prophylaxis In CancerLong-term Viral SheddingOral Viral SheddingViral Shedding Assessment
The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious coronavirus disease (COVID-19) has posed a unique challenge to medical staff, patients and their families. Patients with cancer, particularly those with haematologic malignancies, have been identified to be at high risk to develop severe COVID-19. Since publication of our previous guideline on evidence-based management of COVID-19 in patients with cancer, research efforts have continued and new relevant data has come to light, maybe most importantly in the field of vaccination studies. Therefore, an update of our guideline on several clinically important topics is warranted. Here, we provide a concise update of evidence-based recommendations for rapid diagnostics, viral shedding, vaccination and therapy of COVID-19 in patients with cancer. This guideline update was prepared by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology by critically reviewing the currently available data on these topics applying evidence-based medicine criteria.
38
Dexamethasone in Hospitalized Patients with Covid-19
New England Journal of Medicine · 2020 · 10.1K citations · Full text
Dexamethasone in Hospitalized Patients with Covid-19.
Peter Horby, Wei Shen Lim, Jonathan Emberson et al. · DiRROS repository (University of Maribor) · 2020 · 8K citations · Full text
Remdesivir for the Treatment of Covid-19 — Final Report
John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text